Xin-xin Cao
ORCID: 0000-0001-7884-3073Also affiliated with Qingdao Agricultural University, Shandong University, China Pharmaceutical University, Shanxi University, Chinese Academy of Medical Sciences & Peking Union Medical College, Chang'an University, State Administration of Traditional Chinese Medicine of the People's Republic of China, Peking Union Medical College Hospital, National Cancer Center, Yangtze Optical Electronic (China), Shandong Transportation Research Institute, National Clinical Research, Affiliated Hospital of Hebei University, Shanghai Research Institute of Materials, Fu Wai Hospital, Henan Polytechnic University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 1 paper. Top paper: “Evaluation of orelabrutinib monotherapy in patients with relapsed or refractory Waldenström's macroglobulinemia in a single-arm, multicenter, open-label, phase 2 study”.
Jie Jin, Cheng-cheng Fu, Shu-hua Yi, Wei-li Zhao, Zi-min Sun +15 more